Skip to main content

Short Ragweed

Generic: Ambrosia artemisiifolia

Verified·Apr 23, 2026
Manufacturer
ALK
NDC
0268-7120
RxCUI
896140
Route
CUTANEOUS
ICD-10 indication
J30.1

Affordability Check

How much will you actually pay for Short Ragweed?

In 30 seconds, see every legitimate way to afford Short Ragweed — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Short Ragweed

What is this medication? Short ragweed is an allergen immunotherapy treatment used to reduce symptoms of seasonal allergic rhinitis, commonly known as hay fever, caused by short ragweed pollen. This medication is specifically designed for individuals who have a confirmed sensitivity to this type of pollen as determined by clinical testing. Unlike fast-acting antihistamines, this treatment works by exposing the immune system to small amounts of the allergen, helping the body build a long-term tolerance and reducing the severity of allergic reactions over time.

The medication is typically administered as a sublingual tablet that dissolves under the tongue or as an extract used in allergy shots. Treatment generally begins several weeks before the start of the ragweed pollen season and continues daily throughout the duration of the season. By desensitizing the patient to the pollen, it helps alleviate common symptoms such as sneezing, nasal congestion, and itchy or watery eyes, providing more comprehensive relief than many standard over-the-counter allergy medications.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Short Ragweed. Official source: DailyMed (NLM) · Label effective Jun 5, 2023

Indications and usage
• INDICATIONS AND USAGE For the temporary relief of minor allergy symptoms: Sinus Pressure, runny or itchy nose, Nasal congestion, Allergic Rhinitis, Sneezing, itchy or watery eyes, Allergy related headache, Itchy throat and skin.
Dosage and administration
Directions For max absorption dissolve under tongue. Can be chewed and swallowed. Adults and children 12 years and older: 2 tablets every 4 hours. Do not exceed 12 tablets in 24 hours Children 4 to 11 years: 1-2 tablets every 4 hours. Do not exceed 12 tablets in 24 hours For Children under 4 years, consult your health professional.
Warnings
• WARNINGS If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to ClearLife™ or any of its ingredients exists.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.